# Long-Term Thyroid Complications Post-COVID-19: A Systematic Review

**Authors:** Luai Hommos, Harsh Gohil, Mlaak Rob, Jane Manyama, Haneen Ramy, Nesha Naseem, Hana Nishan, Raghad Sabaawi Ibrahim, Shahad Sabaawi Ibrahim, Vivian Chetachi Eziefula Njoku, Ibrahim Al-Mutawa, Aasiya F. Khan, Sean Holroyd, Dalia Zakaria

PMC · DOI: 10.3390/microorganisms14030543 · Microorganisms · 2026-02-27

## TL;DR

This paper reviews long-term thyroid issues that can occur after recovering from COVID-19, highlighting the need for monitoring and further research.

## Contribution

The study systematically reviews and categorizes long-term thyroid complications following SARS-CoV-2 infection, emphasizing autoimmune-related persistence.

## Key findings

- Long-term thyroid complications after COVID-19 include subacute thyroiditis, thyrotoxicosis, and autoimmune thyroiditis.
- Autoimmune thyroid disorders, such as Graves’ disease, are more likely to persist after SARS-CoV-2 infection.
- Proposed mechanisms for these complications include direct viral damage, cytokine effects, and post-viral autoimmunity.

## Abstract

Coronavirus disease 2019 (COVID-19) is increasingly shown to be a multisystem disorder with long-term complications, including endocrine system complications. The thyroid gland is also susceptible, as it contains ACE2 receptors, making it exposed to both direct viral damage and autoimmune-mediated dysfunction. Recent reports document the various thyroid complications that persist well after the acute infection phase. This systematic review investigates the long-term thyroid complications in individuals with a history of SARS-CoV-2 infection. A comprehensive literature search across several databases was conducted. Eligible studies reported new onset long-term thyroid complications occurring post-COVID-19 infection. Abstract and full-text screening as well as data extraction and quality assessment was performed by two independent reviewers. Only 28 studies met our inclusion criteria, reporting 419 patients from 18 countries. These studies included case reports, case series, cohort, and cross-sectional studies. Reported thyroid disorders included subacute thyroiditis, thyrotoxicosis, hyperthyroidism (including Graves’ disease), isolated high T3/T4, hypothyroidism, central hypothyroidism, and non-thyroidal illness syndrome (NTIS). While many of these eventually resolved, a significant portion persisted or recurred, especially autoimmune thyroiditis. COVID-19 is associated with a range of long-term thyroid complications. Although some cases are temporary, others last, especially autoimmune thyroid disorders. Proposed mechanisms include direct viral cytotoxicity, cytokine-mediated Hypothalamic–Pituitary–Thyroid (HPT) axis suppression, post-viral autoimmunity, vascular injury, and neuroendocrine disruption. Routine thyroid function monitoring in COVID-19 survivors, particularly those with severe disease or persistent symptoms is recommended, and larger prospective studies are needed to better understand incidence and outcomes.

## Linked entities

- **Proteins:** ACE2 (angiotensin converting enzyme 2)
- **Diseases:** Coronavirus disease 2019 (MONDO:0100096), subacute thyroiditis (MONDO:0006982), thyrotoxicosis (MONDO:0010138), hyperthyroidism (MONDO:0004425), Graves’ disease (MONDO:0005364), hypothyroidism (MONDO:0005420), central hypothyroidism (MONDO:0016410)

## Full-text entities

- **Diseases:** hyperthyroidism (MESH:D006980), cytotoxicity (MESH:D064420), Long-Term Thyroid Complications (MESH:D000088562), hypothyroidism (MESH:D007037), thyrotoxicosis (MESH:C566386), vascular injury (MESH:D057772), neuroendocrine disruption (MESH:D018358), infection (MESH:D007239), NTIS (MESH:D005067), COVID-19 (MESH:D000086382), Graves' disease (MESH:D006111), thyroiditis (MESH:D013966), autoimmune thyroid disorders (MESH:D013967), thyroid complications (MESH:D013959), autoimmune-mediated dysfunction (MESH:D001327)
- **Chemicals:** T4 (MESH:D013974), T3 (MESH:D014284)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13029401/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13029401/full.md

## References

85 references — full list in the complete paper: https://tomesphere.com/paper/PMC13029401/full.md

---
Source: https://tomesphere.com/paper/PMC13029401